Clinical Trial Update: Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists [Phase 2]

View source ↗

Summary

This is a Phase 2 randomized discontinuation trial comparing lapatinib to placebo in cancer patients who progressed after chemotherapy or had no approved therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer | Phase 2 | Status: TERMINATED | Results posted: 2010-02-04